Photocure's Partner Asieris Pharmaceuticals Advances Cevira® for Potential Approval in China

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National...

May 13, 2024 | Monday | News
New Dietary Guidelines Released to Combat Nutritional Challenges in India

The National Institute of Nutrition (NIN), under the Indian Council of Medical Research (ICMR), has released updated "Dietary Guide...

May 10, 2024 | Friday | Reports
MSD Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global materna...

May 09, 2024 | Thursday | News
Driving Global Access to Medicines: A Conversation with Cem Zorlular, CEO of Er-Kim

  In an interview with BioPharma BoardRoom, Cem Zorlular, CEO of Er-Kim, shares his personal journey and the driving force behind Er-Kim's mission to...

May 06, 2024 | Monday | Interview
Walgreens and Boehringer Ingelheim Forge Strategic Partnership to Democratize Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusiv...

May 03, 2024 | Friday | News
Beyfortus (nirsevimab) Proves Potent Against RSV Hospitalizations in Infants

New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the...

May 03, 2024 | Friday | News
BrioHealth Solutions Granted FDA Approval to Commence Landmark Trial for Novel Heart Failure Treatment

BrioHealth Solutions, Inc., a medical technology company focused on developing innovative advanced heart failure solutions, announced it has received FDA I...

May 02, 2024 | Thursday | News
NKGen Biotech's SNK01 NK Cell Therapy Clears FDA IND Hurdle for Parkinson’s

The Company expects to initiate a Phase 1 clinical trial in PD in 2H 2024. NKGen Biotech, Inc. , a clinical-stage biotechnology company focused on the dev...

April 30, 2024 | Tuesday | News
Hyundai Bioscience Announces Clinical Development Plan for Oral Niclosamide Metabolic Anticancer Drug Targeting p53 Gene Mutations

Hyundai Bioscience announced its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cance...

April 25, 2024 | Thursday | News
Gain Therapeutics Reports Positive Results from Phase 1 Study of GT-02287, Showcasing Promising Safety and Tolerability Profile

Gain Therapeutics, a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapi...

April 25, 2024 | Thursday | News
SAS Empowers Public Health Researchers with New Tool for Analyzing NIH's All of Us Research Program Data

Public health researchers have a new, powerful tool from data and AI provider SAS to analyze the National Institutes of Health's All of Us Research Program...

April 24, 2024 | Wednesday | News
Ipsen Strikes Option Agreement with Skyhawk for Exclusive Global Rights to Novel Neurological Disease Candidates

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaboration Following development candida...

April 22, 2024 | Monday | News
GE HealthCare Launches Voluson Signature 20 and 18 Ultrasound Systems Revolutionizing Women's Health Diagnosis

GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which comprehensively integrate artificial intelligence (AI), adv...

April 18, 2024 | Thursday | News
DoseMe Expands Global Footprint as Premier Hospitals and Cancer Centers across Australia Continue to Adopt Bayesian Dosing

    -DoseMe, a leading provider of model-informed precision dosing (MIPD) software, is pleased to announce the continued growth in Au...

April 17, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close